OAM
RMD icon

Occidental Asset Management’s ResMed RMD Stock Holding History

Occidental Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,163
Closed -$485K – 339
2026
Q1 		$485K Buy
2,163
+464
+27% +$116K 0.06% 166
2025
Q4 		$409K Buy
1,699
+49
+3% +$12.5K 0.05% 176
2025
Q3 		$452K Buy
1,650
+80
+5% +$21.9K 0.06% 171
2025
Q2 		$405K Sell
1,570
-1
-0.1% -$239 0.06% 166
2025
Q1 		$352K Buy
1,571
+118
+8% +$27.5K 0.05% 170
2024
Q4 		$332K Buy
+1,453
New +$350K 0.05% 157
2022
Q1 		– Sell
-800
Closed -$208K – 212
2021
Q4 		$208K Hold
800
– – 0.05% 199
2021
Q3 		$211K Buy
+800
New +$219K 0.05% 197

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Occidental Asset Management's RMD Position: Q2 2026 in Review

Occidental Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,163 shares — an estimated $485K sold.

Occidental Asset Management first reported a position in RMD in Q3 2021 and held it in 8 quarters. The position peaked at $485K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Occidental Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Occidental Asset Management sold 2,163 ResMed shares in Q2 2026, an estimated $485K.
  • Occidental Asset Management first reported a position in ResMed in Q3 2021 and held it in 8 quarters.
  • Occidental Asset Management's ResMed position peaked at $485K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Occidental Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.